G1 THERAPEUTICS, INC. Operating Expenses
G1 THERAPEUTICS, INC. reported Operating Expenses of $20.08 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-08-08
- G1 THERAPEUTICS, INC. operating expenses for the quarter ending 2024-06-30 was $20.08M, a 34.96% decline year-over-year.
- G1 THERAPEUTICS, INC. operating expenses for the quarter ending 2024-03-31 was $23.52M, a 39.20% decline year-over-year.
- G1 THERAPEUTICS, INC. operating expenses for the quarter ending 2023-12-31 was $23.80M, a 42.14% decline year-over-year.
- G1 THERAPEUTICS, INC. operating expenses for the quarter ending 2023-09-30 was $28.67M, a 36.47% decline year-over-year.
- G1 THERAPEUTICS, INC. operating expenses for fiscal 2023 was $122.04M, a 34.91% decline from fiscal 2022.
- G1 THERAPEUTICS, INC. operating expenses for fiscal 2022 was $187.48M, a 7.79% increase from fiscal 2021.
- G1 THERAPEUTICS, INC. operating expenses for fiscal 2021 was $173.93M, a 22.69% increase from fiscal 2020.
- G1 THERAPEUTICS, INC. operating expenses for fiscal 2020 was $141.76M, a 9.86% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-06-30 | $20.08M 10-Q · filed 2024-08-08 | $43.60M 10-Q · filed 2024-08-08 | $67.41M derived: sum of 3 quarters · filed 2024-08-08 | $96.08M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $23.52M 10-Q · filed 2024-05-01 | $47.33M derived: sum of 2 quarters · filed 2024-05-01 | $75.99M derived: sum of 3 quarters · filed 2024-05-01 | $106.87M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $23.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $52.47M derived: sum of 2 quarters · filed 2024-02-28 | $83.35M derived: sum of 3 quarters · filed 2024-08-08 | $122.04M 10-K · filed 2024-02-28 |
| 2023-09-30 | $28.67M 10-Q · filed 2023-11-01 | $59.54M derived: sum of 2 quarters · filed 2024-08-08 | $98.24M 10-Q · filed 2023-11-01 | $139.37M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $30.88M 10-Q · filed 2024-08-08 | $69.57M 10-Q · filed 2024-08-08 | $110.70M derived: sum of 3 quarters · filed 2024-08-08 | $155.83M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $38.69M 10-Q · filed 2024-05-01 | $79.83M derived: sum of 2 quarters · filed 2024-05-01 | $124.95M derived: sum of 3 quarters · filed 2024-05-01 | $172.49M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $41.14M 10-K · filed 2023-03-01 | $86.26M derived: sum of 2 quarters · filed 2023-11-01 | $133.80M derived: sum of 3 quarters · filed 2023-11-01 | $187.48M 10-K · filed 2024-02-28 |
| 2022-09-30 | $45.12M 10-Q · filed 2023-11-01 | $92.66M derived: sum of 2 quarters · filed 2023-11-01 | $146.34M 10-Q · filed 2023-11-01 | $189.72M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $47.53M 10-Q · filed 2023-08-02 | $101.22M 10-Q · filed 2023-08-02 | $144.60M derived: sum of 3 quarters · filed 2023-08-02 | $190.60M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $53.68M 10-Q · filed 2023-05-03 | $97.06M derived: sum of 2 quarters · filed 2023-05-03 | $143.07M derived: sum of 3 quarters · filed 2023-05-03 | $187.86M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $43.38M 10-K · filed 2023-03-01 | $89.38M derived: sum of 2 quarters · filed 2023-03-01 | $134.18M derived: sum of 3 quarters · filed 2023-03-01 | $173.93M 10-K · filed 2024-02-28 |
| 2021-09-30 | $46.00M 10-K · filed 2023-03-01 | $90.80M derived: sum of 2 quarters · filed 2023-03-01 | $130.55M 10-Q · filed 2022-11-02 | $171.19M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $44.80M 10-K · filed 2023-03-01 | $84.55M 10-Q · filed 2022-08-03 | $125.18M derived: sum of 3 quarters · filed 2023-03-01 | $161.53M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $39.75M 10-K · filed 2023-03-01 | $80.39M derived: sum of 2 quarters · filed 2023-03-01 | $116.73M derived: sum of 3 quarters · filed 2023-03-01 | $149.69M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $40.63M 10-K · filed 2022-02-23 | $76.98M derived: sum of 2 quarters · filed 2022-02-23 | $109.94M derived: sum of 3 quarters · filed 2022-02-23 | $141.76M 10-K · filed 2023-03-01 |
| 2020-09-30 | $36.34M 10-K · filed 2022-02-23 | $69.31M derived: sum of 2 quarters · filed 2022-02-23 | $101.13M 10-Q · filed 2021-11-03 | $137.68M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $32.96M 10-K · filed 2022-02-23 | $64.78M 10-Q · filed 2021-08-04 | $101.34M derived: sum of 3 quarters · filed 2022-02-23 | $135.36M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $31.82M 10-K · filed 2022-02-23 | $68.37M derived: sum of 2 quarters · filed 2022-02-23 | $102.40M derived: sum of 3 quarters · filed 2022-02-23 | $134.98M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $36.55M 10-K · filed 2021-02-24 | $70.58M derived: sum of 2 quarters · filed 2021-02-24 | $103.16M derived: sum of 3 quarters · filed 2021-02-24 | $129.04M 10-K · filed 2022-02-23 |
| 2019-09-30 | $34.02M 10-K · filed 2021-02-24 | $66.61M derived: sum of 2 quarters · filed 2021-02-24 | $92.49M 10-Q · filed 2020-11-04 | $118.57M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $32.58M 10-K · filed 2021-02-24 | $58.47M 10-Q · filed 2020-08-05 | $84.55M derived: sum of 3 quarters · filed 2021-02-24 | $105.37M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $25.88M 10-K · filed 2021-02-24 | $51.97M derived: sum of 2 quarters · filed 2021-02-24 | $72.79M derived: sum of 3 quarters · filed 2021-02-24 | $94.44M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $26.09M 10-K · filed 2020-02-26 | $46.91M derived: sum of 2 quarters · filed 2020-02-26 | $68.56M derived: sum of 3 quarters · filed 2020-02-26 | $89.29M 10-K · filed 2021-02-24 |
| 2018-09-30 | $20.82M 10-K · filed 2020-02-26 | $42.48M derived: sum of 2 quarters · filed 2020-02-26 | $63.20M 10-Q · filed 2019-11-05 | $80.48M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $21.65M 10-K · filed 2020-02-26 | $42.38M 10-Q · filed 2019-08-07 | $59.66M derived: sum of 3 quarters · filed 2020-02-26 | $75.59M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $20.73M 10-K · filed 2020-02-26 | $38.01M derived: sum of 2 quarters · filed 2020-02-26 | $53.94M derived: sum of 3 quarters · filed 2020-02-26 | $69.31M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $17.28M 10-K · filed 2019-02-28 | $33.21M derived: sum of 2 quarters · filed 2019-02-28 | $48.59M derived: sum of 3 quarters · filed 2019-02-28 | $60.97M 10-K · filed 2020-02-26 |
| 2017-09-30 | $15.93M 10-K · filed 2019-02-28 | $31.31M derived: sum of 2 quarters · filed 2019-02-28 | $43.69M 10-Q · filed 2018-11-07 | $54.09M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $15.38M 10-K · filed 2019-02-28 | $27.76M 10-Q · filed 2018-08-08 | $38.16M derived: sum of 3 quarters · filed 2019-02-28 | $44.77M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $12.38M 10-K · filed 2019-02-28 | $22.78M derived: sum of 2 quarters · filed 2019-02-28 | $29.39M derived: sum of 3 quarters · filed 2019-02-28 | $36.82M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $10.40M 10-K · filed 2018-02-21 | $17.02M derived: sum of 2 quarters · filed 2018-02-21 | $24.45M derived: sum of 3 quarters · filed 2018-02-21 | $30.39M 10-K · filed 2019-02-28 |
| 2016-09-30 | $6.61M 10-K · filed 2018-02-21 | $14.04M derived: sum of 2 quarters · filed 2018-02-21 | $19.99M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $7.43M 10-K · filed 2018-02-21 | $13.38M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $5.95M 10-K · filed 2018-02-21 | |||
| 2015-12-31 | $15.95M 10-K · filed 2018-02-21 |